Dr Reddy Share Price Target 2024 To 2030 – Dr Reddy’s Laboratories Ltd. is a global pharmaceutical company based in India. It offers a variety of products and services, including active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars, and over-the-counter (OTC) products. The company’s profit after tax for FY 2021-2022 was Rs 2,182.50 crore, with total assets of Rs 29,746.90 crore.
The promoter stake is 26.71%, the foreign institutional investor stake is 25.87%, and the public stake is 21.96%. The company’s share price is regularly updated on the NSE and BSE.
Dr Reddy Share Price Current Market Overview
- Today’s Open: 6534.80Â
- Today’s High:  6597.95
- Today’s Low:  6485.70
- Current Share Price:Â 6,635.90
- Market Capital: Â 109318
- P/E:Â 49.31
- Dividend Yield: 0.61
- 52 Week High: Â 7107.95 Â
- 52 Week Low: Â 5205.55
Dr Reddy Share Price Recent Graph
Dr Reddy Share Price Target Tomorrow From 2024 To 2030
This analysis for upcoming years is based on market valuation, industrial trends, and expert analysis.
| S. No. | Share Price Target Years | Share Target Value |
|
|
2024 | 7,200 |
|
|
2025 | 8,100 |
|
|
2026 | 9,000 |
|
|
2027 | 10,010 |
|
|
2028 | 11,161 |
|
|
2029 | 12,000 |
|
|
2030 | 14,555 |
Shareholding Pattern For Dr Reddy Share Price
- Promoters: 65.41%
- Foreign Institutions: 10.13%
- Domestic Institutions: Â 1.8%
- Public: 22.6%
- Other: Â 0.06%
Challenges For Dr Reddy’s Share Price
- Regulatory Risks: Political risks This is a risk which emanates from shifting government policies and regulations that might affect the firm’s revenues and operation.
- Interest Rate Fluctuations: High inflation leads to increased interest rates, and this makes the cost of borrowing high, and hence the profitability margin shrinks.
- Operational Risks: Any disruptions or indicators of a decline in the execution of the project will have a potential impact on revenues.
- Market Competition: Rising competitive industry pressures might ensue and lower margins in the power transmission space.
Dr Reddy Share Price For Annual Income Statement
 For detailed information regarding the annual income statement, refer to the given data.Â
| Particulars | Info 2024 | Y/Y Change |
| Revenue | 76.73B | +13.87% |
| Operating Expenses | 28.40B | +29.68% |
| Net Income | 13.92B | -0.75% |
| Net Profit Margin | 18.14 | -12.83% |
| Earning Per Share | 83.48 | -0.94% |
| EBITDA | 21.76B | +2.51% |
| Effective Tax Rate | 26.04% | N/A |
